CD44v6 Drives Tumor Aggressiveness and Chemoresistance in Bladder Cancer
Iris Lodewijk(Hospital Universitario 12 De Octubre), Marta Dueñas(Research Institute Hospital 12 de Octubre), Omaira Alberquilla(Cipher Gene (China)), Lucía Parrilla, Álvaro Martín de Bernardo, Félix Guerrero‐Ramos(Research Institute Hospital 12 de Octubre), Miguel Rodríguez Alonso, Rebeca Sánchez‐Domínguez, Esther Montesinos, Gottfrid Sjödahl(Lund University), José Luis Rodríguez‐Peralto(Research Institute Hospital 12 de Octubre), Pontus Eriksson(Lund University), Jesús M. Paramio(Universidad Complutense de Madrid), Cristian Suárez-Cabrera(Research Institute Hospital 12 de Octubre), Lucía Morales, Rosa García, Daniel Castellano, Carolina Rubio
Cited by 0
Related Papers
A Consensus Molecular Classification of Muscle-invasive Bladder Cancer
|European Urology|2019|1.4k
A Molecular Taxonomy for Urothelial Carcinoma
|Clinical Cancer Research|2012|1k
Impact of Molecular Subtypes in Muscle-invasive Bladder Cancer on Predicting Response and Survival after Neoadjuvant Chemotherapy
|European Urology|2017|798
Cutaneous Lymphoma International Consortium Study of Outcome in Advanced Stages of Mycosis Fungoides and Sézary Syndrome: Effect of Specific Prognostic Markers on Survival and Development of a Prognostic Model
|Journal of Clinical Oncology|2015|419
An integrated multi-omics analysis identifies prognostic molecular subtypes of non-muscle-invasive bladder cancer
|Nature Communications|2021|386